PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSimeticone
Simeticone
Simeticone is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
phazymeC2002632025-02-04
phazyme ultimateC2002632024-08-14
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
103 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients81110
ColonoscopyD0031132428
Irritable bowel syndromeD043183EFO_0000555K581326
Capsule endoscopyD053704145
ColicD003085R10.832125
DiarrheaD003967R19.711215
Colonic polypsD003111K63.51225
SyndromeD0135771225
Intestinal diseasesD007410K63.91124
AdenomaD000236224
Show 20 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gastrointestinal diseasesD0057672136
Colorectal neoplasmsD015179145
DyspepsiaD004415EFO_0008533K301214
Stomach diseasesD0132721124
HypertensionD006973EFO_0000537I10333
Portal hypertensionD006975EFO_0000666K76.6333
VomitingD014839R11.1112
HemorrhageD006470MP_0001914R58112
Gastrointestinal hemorrhageD006471K92.2112
ConstipationD003248K59.0112
Show 11 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Digestive system diseasesD004066EFO_0000405K92.9235
Autism spectrum disorderD000067877F84.0112
Ovarian neoplasmsD010051EFO_0003893C5611
Ovarian epithelial carcinomaD00007721611
Pathologic complete responseD00009538411
Otitis mediaD010033EFO_0004992H66.911
OtitisD01003111
Diabetes complicationsD04890911
Macular edemaD00826911
Diabetic retinopathyD003930EFO_000377011
Show 5 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Abdominal painD015746EFO_0003766R10.9112
Hiv infectionsD015658EFO_0000764B2022
Traumatic brain injuriesD000070642S0611
Brain concussionD001924S06.011
Brain injuriesD001930S06.911
Post-traumatic stress disordersD013313EFO_0001358F43.111
Traumatic stress disordersD04092111
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Mitral valve insufficiencyD00894411
Gastroesophageal refluxD005764EFO_0003948K2111
Peptic esophagitisD004942EFO_100109511
CoughD003371R0511
Chronic coughD000096822R05.311
Rectal neoplasmsD01200411
PolypsD011127EFO_000066211
GastroscopyD00577311
Covid-19D000086382U07.111
Lactose intoleranceD007787E7311
Show 10 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSimeticone
INN
Description
Simeticone (INN), also known as simethicone (USAN), is an anti-foaming agent used to reduce bloating, discomfort or pain caused by excessive gas.
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2108741
ChEBI ID
PubChem CID
DrugBankDB09512
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
101 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use